

[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
Erin Wright Maintained (CAH) at Buy with Increased Target to $90 on, Feb 3rd, 2023
Erin Wright of Morgan Stanley, Maintained "Cardinal Health, Inc." (CAH) at Buy with Increased Target from $86 to $90 on, Feb 3rd, 2023.
Erin has made no other calls on CAH in the last 4 months.
There are 4 other peers that have a rating on CAH. Out of the 4 peers that are also analyzing CAH, 3 agree with Erin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- A.J. Rice of "Credit Suisse" Maintained at Hold with Increased Target to $79 on, Tuesday, November 22nd, 2022
- Ann Hynes of "Mizuho" Maintained at Hold with Increased Target to $74 on, Monday, November 14th, 2022
- Michael Cherny of "B of A Securities" Upgraded from Sell to Hold and Increased Target to $80 on, Friday, November 4th, 2022
This is the rating of the analyst that currently disagrees with Erin
- Kevin Caliendo of "UBS" Maintained at Strong Buy with Increased Target to $91 on, Tuesday, January 31st, 2023
Contributing Sources